Literature DB >> 31332457

Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients.

Montserrat Pazos1, Franziska Walter2, Daniel Reitz1, Stephan Schönecker1, Dinah Konnerth1, Annemarie Schäfer1, Maya Rottler1, Filippo Alongi3,4, Philipp Freislederer1, Maximilian Niyazi1, Claus Belka1, Stefanie Corradini1.   

Abstract

OBJECTIVE: The impact of optical surface guidance on the use of portal imaging and the initial set-up duration in patients receiving postoperative radiotherapy of the breast or chest wall was investigated.
MATERIAL AND METHODS: A retrospective analysis was performed including breast cancer patients who received postoperative radiotherapy between January 2016 and December 2016. One group of patients received treatment before the optical surface scanner was installed (no-OSS) and the other group was positioned using the additional information derived by the optical surface scanner (OSS). The duration of the initial set-up was recorded for each patient and a comparison of both groups was performed. Accordingly, the differences between planned and actually acquired portal images during the course of radiotherapy were compared between both groups.
RESULTS: A total of 180 breast cancer patients were included (90 no-OSS, 90 OSS) in this analysis. Of these, 30 patients with left-sided breast cancer received radiotherapy in deep inspiration breath hold (DIBH). The mean set-up time was 10 min and 18 s and no significant difference between the two groups of patients was found (p = 0.931). The mean set-up time in patients treated without DIBH was 9 min and 45 s compared to 13 min with DIBH (p < 0.001), as portal imaging was performed in DIBH. No significant difference was found in the number of acquired to the planned number of portal images during the entire radiotherapy treatment for both groups (p = 0.287).
CONCLUSION: Optical surface imaging is a valuable addition for primary patient set-up. The findings confirm that the addition of surface-based imaging did not prolong the clinical workflow and had no significant impact on the number of portal verification images carried out during the course of radiotherapy.

Entities:  

Keywords:  Breast cancer; Duration; IGRT; Optical surface scanner; Patient positioning; Portal imaging

Mesh:

Year:  2019        PMID: 31332457     DOI: 10.1007/s00066-019-01494-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

Review 1.  Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.

Authors:  David Krug; René Baumann; Wilfried Budach; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Thomas Hehr; Marc D Piroth; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2018-07-04       Impact factor: 3.621

2.  Trends in use and outcome of postoperative radiotherapy following mastectomy: A population-based study.

Authors:  Stefanie Corradini; Ingo Bauerfeind; Claus Belka; Michael Braun; Stephanie E Combs; Renate Eckel; Nadia Harbeck; Dieter Hölzel; Marion Kiechle; Maximilian Niyazi; Jutta Engel
Journal:  Radiother Oncol       Date:  2016-09-15       Impact factor: 6.280

3.  Three-dimensional surface scanning for accurate patient positioning and monitoring during breast cancer radiotherapy.

Authors:  C Gaisberger; P Steininger; B Mitterlechner; S Huber; H Weichenberger; F Sedlmayer; H Deutschmann
Journal:  Strahlenther Onkol       Date:  2013-06-07       Impact factor: 3.621

4.  A novel surface imaging system for patient positioning and surveillance during radiotherapy. A phantom study and clinical evaluation.

Authors:  F Stieler; F Wenz; M Shi; F Lohr
Journal:  Strahlenther Onkol       Date:  2013-09-27       Impact factor: 3.621

5.  Clinical evaluation of a commercial surface-imaging system for patient positioning in radiotherapy.

Authors:  F Stieler; F Wenz; D Scherrer; M Bernhardt; F Lohr
Journal:  Strahlenther Onkol       Date:  2012-11-10       Impact factor: 3.621

6.  Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold.

Authors:  Montserrat Pazos; Alba Fiorentino; Aurélie Gaasch; Stephan Schönecker; Daniel Reitz; Christian Heinz; Maximilian Niyazi; Marciana-Nona Duma; Filippo Alongi; Claus Belka; Stefanie Corradini
Journal:  Strahlenther Onkol       Date:  2018-08-24       Impact factor: 3.621

7.  Treatment planning and evaluation of gated radiotherapy in left-sided breast cancer patients using the CatalystTM/SentinelTM system for deep inspiration breath-hold (DIBH).

Authors:  S Schönecker; F Walter; P Freislederer; C Marisch; H Scheithauer; N Harbeck; S Corradini; C Belka
Journal:  Radiat Oncol       Date:  2016-10-26       Impact factor: 3.481

8.  Evaluation of daily patient positioning for radiotherapy with a commercial 3D surface-imaging system (Catalyst™).

Authors:  F Walter; P Freislederer; C Belka; C Heinz; M Söhn; F Roeder
Journal:  Radiat Oncol       Date:  2016-11-24       Impact factor: 3.481

9.  Radiotherapy setup displacements in breast cancer patients: 3D surface imaging experience.

Authors:  Ana Cravo Sá; Ana Fermento; Dalila Neves; Sara Ferreira; Teresa Silva; Carina Marques Coelho; Aude Vaandering; Ana Roma; Sérgio Quaresma; Emmanuel Bonnarens
Journal:  Rep Pract Oncol Radiother       Date:  2018-01-16

10.  Can surface imaging improve the patient setup for proton postmastectomy chest wall irradiation?

Authors:  Estelle Batin; Nicolas Depauw; Shannon MacDonald; Hsiao-Ming Lu
Journal:  Pract Radiat Oncol       Date:  2016-02-11
View more
  5 in total

1.  Prerequisites for the clinical implementation of a markerless SGRT-only workflow for the treatment of breast cancer patients.

Authors:  Tim-Oliver Sauer; Oliver J Ott; Godehard Lahmer; Rainer Fietkau; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2022-07-04       Impact factor: 3.621

2.  Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer.

Authors:  D Reitz; F Walter; S Schönecker; P Freislederer; M Pazos; M Niyazi; G Landry; F Alongi; E Bölke; C Matuschek; M Reiner; C Belka; S Corradini
Journal:  Radiat Oncol       Date:  2020-05-24       Impact factor: 3.481

Review 3.  X-change symposium: status and future of modern radiation oncology-from technology to biology.

Authors:  Stefanie Corradini; Maximilian Niyazi; Dirk Verellen; Vincenzo Valentini; Seán Walsh; Anca-L Grosu; Kirsten Lauber; Amato Giaccia; Kristian Unger; Jürgen Debus; Bradley R Pieters; Matthias Guckenberger; Suresh Senan; Wilfried Budach; Roland Rad; Julia Mayerle; Claus Belka
Journal:  Radiat Oncol       Date:  2021-02-04       Impact factor: 4.309

Review 4.  Recent advanced in Surface Guided Radiation Therapy.

Authors:  P Freislederer; M Kügele; M Öllers; A Swinnen; T-O Sauer; C Bert; D Giantsoudi; S Corradini; V Batista
Journal:  Radiat Oncol       Date:  2020-07-31       Impact factor: 3.481

5.  Radiotherapy in oncological emergencies: fast-track treatment planning.

Authors:  Lukas Nierer; Franziska Walter; Maximilian Niyazi; Roel Shpani; Guillaume Landry; Sebastian Marschner; Rieke von Bestenbostel; Dominika Dinkel; Gabriela Essenbach; Michael Reiner; Claus Belka; Stefanie Corradini
Journal:  Radiat Oncol       Date:  2020-09-10       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.